The overarching challenge that faces technology-driven drug discovery is how to achieve horizontal integration of each R&D phase so that progress from one to the next will "translate" into clinical success - i.e. translational medicine. In response to this challenge, pharmaceutical companies are enabling translational medicine initiatives that are charged with coordinating efficacy-based preclinical activity with clinical medicine.
MDS Pharma Services is pleased to highlight the following efficacy pharmacology model(s) that serve in this purpose. For additional preclinical efficacy models, please inquire at www.mdsinc.com.
|